000 02005 a2200625 4500
005 20250518054853.0
264 0 _c20200707
008 202007s 0 0 eng d
022 _a1538-8514
024 7 _a10.1158/1535-7163.MCT-19-0170
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHao, Huai-Xiang
245 0 0 _aTumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers.
_h[electronic resource]
260 _bMolecular cancer therapeutics
_c12 2019
300 _a2368-2380 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCell Line, Tumor
650 0 4 _aDisease Models, Animal
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aProtein Tyrosine Phosphatase, Non-Receptor Type 11
_xantagonists & inhibitors
650 0 4 _aProto-Oncogene Proteins p21(ras)
_xgenetics
650 0 4 _aSignal Transduction
650 0 4 _aTachykinins
_xantagonists & inhibitors
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aWang, Hongyun
700 1 _aLiu, Chen
700 1 _aKovats, Steven
700 1 _aVelazquez, Roberto
700 1 _aLu, Hengyu
700 1 _aPant, Bhavesh
700 1 _aShirley, Matthew
700 1 _aMeyer, Matthew J
700 1 _aPu, Minying
700 1 _aLim, Joanne
700 1 _aFleming, Michael
700 1 _aAlexander, LeighAnn
700 1 _aFarsidjani, Ali
700 1 _aLaMarche, Matthew J
700 1 _aMoody, Susan
700 1 _aSilver, Serena J
700 1 _aCaponigro, Giordano
700 1 _aStuart, Darrin D
700 1 _aAbrams, Tinya J
700 1 _aHammerman, Peter S
700 1 _aWilliams, Juliet
700 1 _aEngelman, Jeffrey A
700 1 _aGoldoni, Silvia
700 1 _aMohseni, Morvarid
773 0 _tMolecular cancer therapeutics
_gvol. 18
_gno. 12
_gp. 2368-2380
856 4 0 _uhttps://doi.org/10.1158/1535-7163.MCT-19-0170
_zAvailable from publisher's website
999 _c30032009
_d30032009